AYUSH 64 found useful in the treatment of mild to moderate COVID-19 infection
NEW DELHI: In the middle of the havoc wreaked by second wave of the pandemic, AYUSH-64 has emerged as a...
NEW DELHI: In the middle of the havoc wreaked by second wave of the pandemic, AYUSH-64 has emerged as a...
NEW DELHI: Zydus Cadila today announced that the company has received Restricted Emergency Use Approval from the Drug Controller General...